Home > Insider Trading > Filing (0001140361-10-022412)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061983	Cytokinetics Inc	CYTK	Pharmaceutical Preparations (2834)	943291317

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1288952	Michael Schmertzler	C/O Credit Suisse Eleven Madison Avenue New York NY 10010		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Disposition	2010-05-19	16,239	$3.00	4,403,913	No	4	S	Indirect	See Footnote 2

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote 2

Footnotes

Represents the average per share sale price.
The post transaction share total of 4,403,913 is represented by the following: (a) 3,278,221 shares of Common Stock held by Credit Suisse First Boston Equity Partners, L.P.; (b) 916,345 shares of Common Stock held by Credit Suisse First Boston Equity Partners (Bermuda), L.P.; (c) 2,916 shares of Common Stock held by Credit Suisse First Boston U.S. Executive Advisors, L.P.; (d) 88,766 shares of Common Stock held by EMA Partners Fund 2000, L.P.; and (e) 117,665 shares of Common Stock held by EMA Private Equity Fund 2000, L.P. Such amounts include shares of Common Stock issuable upon exercise of warrants previously reported in May 2009. Mr. Schmertzler is a Managing Director of Aries Advisors, LLC, the sub-advisor to Credit Suisse First Boston Equity Partners, L.P. Mr. Schmertzler disclaims beneficial ownership of the shares held by entities affiliated with Credit Suisse except to the extent of his proportionate partnership or membership interest, if any, therein.